SARS-CoV-2 Envelope Protein Polyklonaler Antikörper

SARS-CoV-2 Envelope Protein Polyklonal Antikörper für ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

Virus und mehr (1)

Anwendung

WB, IF, ELISA

Konjugation

Unkonjugiert

Publikationen(3)

Kat-Nr. : 28904-1-AP

Synonyme

COV19, COV-19, COVID19, COVID-19 E protein, E Protein, envelope protein, SARS-COV-2 E Protein, SARS-CoV-2 Envelope Protein



Geprüfte Anwendungen

Erfolgreiche Detektion in ELISARecombinant protein

Empfohlene Verdünnung

AnwendungVerdünnung
Enzyme-linked Immunosorbent Assay (ELISA)ELISA :
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

WBSee 1 publications below
IFSee 3 publications below

Produktinformation

28904-1-AP bindet in WB, IF, ELISA SARS-CoV-2 Envelope Protein und zeigt Reaktivität mit Virus

Getestete Reaktivität Virus
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen SARS-CoV-2 Envelope Protein fusion protein Ag30690
Vollständiger Name COVID-19 E Protein
GenBank-ZugangsnummerNC_045512
Gene symbol SARS-CoV-2 Envelope Protein
Gene ID (NCBI) 43740570
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenStore at -20°C. Stable for one year after shipment. Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).

Publikationen

SpeciesApplicationTitle
WB,IF

bioRxiv

Ubiquitin Ligase ITCH Regulates Life Cycle of SARS-CoV-2 Virus

Authors - Qiwang Xiang
humanIF

iScience

TLR2/NF-κB signaling in macrophage/microglia mediated COVID-pain induced by SARS-CoV-2 envelope protein

Authors - Huan Cui
humanIF

Front Cell Neurosci

The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model

Authors - Jiahang Ju